TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis
Open Access
- 2 February 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Virulence
- Vol. 12 (1), 570-583
- https://doi.org/10.1080/21505594.2021.1879471
Abstract
Pattern recognition receptors (PRRs) are responsible for Aspergillus fumigatus recognition by innate immunity and its subsequent immune signaling. The triggering receptor expressed on myeloid cells 1 (TREM1) is a recently characterized pro-inflammatory receptor constitutively expressed on the surface of neutrophils and macrophages. A soluble form (sTREM1) of this protein that can be detected in human body fluids has been identified. Here we investigated the role of TREM1 during invasive pulmonary aspergillosis (IPA). IPA patients displayed significantly higher levels of sTREM1 in bronchoalveolar lavages when compared to control patients. Functional analysis in TREM1 showed that the levels of sTREM1 and TREM1 pathway-related cytokines were influenced by single nucleotide polymorphisms in TREM1. In addition, we confirmed a role of TREM1 on antifungal host defense against A. fumigatus in a murine model of IPA. TREM1 deficiency increased susceptibility to infection in the immunosuppressed murine host. Deletion of TREM1 showed delayed innate and adaptive immune responses and impaired pro-inflammatory cytokine responses. The absence of TREM1 in primary macrophages attenuated the TLR signaling by altering the expression of both receptor and effector proteins that are critical to the response against A. fumigatus. In this study, and for the first time, we demonstrate the key role for the TREM1 receptor pathway during IPA.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (PTDC/SAU-SER/29635/2017)
- Fundação para a Ciência e a Tecnologia (UIDB/50026/2020 and UIDP/50026/2020)
- Fundação para a Ciência e a Tecnologia (PTDC/MED-GEN/28778/2017)
- H2020 Excellent Science (NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023))
- Instituto de Salud Carlos III (RD16/CIII/0004/0003)
- Instituto de Salud Carlos III (PI18CIII/00045)
- Instituto de Salud Carlos III (MPY 1277/15)
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-099114-B-I00)
- Associação Viver a Ciência (SFRH/BD/136814/2018)
- “la Caixa” Foundation (ID 100010434)
This publication has 49 references indexed in Scilit:
- TREM-1 modulation produces positive outcome on the histopathology and cytokines release profile of Plasmodium berghei-infected miceJournal of Parasitic Diseases, 2018
- Role of Triggering Receptor Expressed on Myeloid Cells-1/3 inKlebsiella-Derived PneumosepsisAmerican Journal of Respiratory Cell and Molecular Biology, 2015
- IL-1α Signaling Is Critical for Leukocyte Recruitment after Pulmonary Aspergillus fumigatus ChallengePLoS Pathogens, 2015
- Triggering receptor expressed on myeloid cells receptor family modulators: a patent reviewExpert Opinion on Therapeutic Patents, 2014
- The Immune Interplay between the Host and the Pathogen inAspergillus fumigatusLung InfectionBioMed Research International, 2013
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) DatabaseClinical Infectious Diseases, 2010
- In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosisBMC Microbiology, 2010
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Crystal Structure of Human Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) at 1.47ÅJournal of Molecular Biology, 2004
- Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and MonocytesThe Journal of Immunology, 2000